|
humans |
37 |
|
male |
35 |
|
female |
26 |
|
middle aged |
26 |
|
medical sciences |
25 |
|
adult |
24 |
|
stroke |
23 |
|
aged |
20 |
|
hypertension |
15 |
|
intracerebral hemorrhage |
15 |
|
blood pressure |
13 |
|
adolescent |
11 |
|
age-related resting state |
10 |
|
child |
10 |
|
eeg power |
10 |
|
magnetic resonance imaging |
10 |
|
source reconstruction |
10 |
|
wavelet entropy |
10 |
|
young adult |
10 |
|
anisotropy |
9 |
|
family health |
9 |
|
ischemic stroke |
9 |
|
aged, 80 and over |
8 |
|
blood pressure variability |
8 |
|
brain - pathology |
8 |
|
cardiovascular and cerebrovascular diseases |
8 |
|
electromyography |
8 |
|
mortality |
8 |
|
neuropathy |
8 |
|
survivors |
8 |
|
vascular markers |
8 |
|
5' untranslated regions - genetics |
7 |
|
adipocytes - metabolism - pathology |
7 |
|
animals |
7 |
|
antiplatelet medication |
7 |
|
asian continental ancestry group - ethnology |
7 |
|
biological markers - blood |
7 |
|
brain - physiology |
7 |
|
brain ischemia - blood - diagnosis - mortality |
7 |
|
charcot-marie-tooth |
7 |
|
charcot-marie-tooth disease - genetics - pathology - physiopathology |
7 |
|
connexins - genetics |
7 |
|
cutoff |
7 |
|
dna mutational analysis |
7 |
|
fatty acid-binding proteins - blood |
7 |
|
genetic diseases, x-linked - genetics |
7 |
|
gjb1 (connexin32) |
7 |
|
hematoma location |
7 |
|
lacunar infarct |
7 |
|
microscopy, electron, transmission |
7 |
|
mutation |
7 |
|
neural conduction - genetics - physiology |
7 |
|
non-coding region |
7 |
|
peripheral nerves - pathology - physiopathology - ultrastructure |
7 |
|
point mutation - genetics |
7 |
|
prognosis |
7 |
|
sequence analysis |
7 |
|
stroke - blood - diagnosis - mortality |
7 |
|
stroke outcome |
7 |
|
tomography, x-ray computed |
7 |
|
aging |
6 |
|
aging - pathology |
6 |
|
alzheimer disease - pathology |
6 |
|
alzheimer's disease |
6 |
|
amyotrophic lateral sclerosis - genetics |
6 |
|
asian continental ancestry group |
6 |
|
brain mapping |
6 |
|
case-control studies |
6 |
|
child, preschool |
6 |
|
china |
6 |
|
ciliary neurotrophic factor - genetics |
6 |
|
cntf |
6 |
|
cognition - physiology |
6 |
|
coronary artery disease |
6 |
|
diagnosis, differential |
6 |
|
diffusion magnetic resonance imaging |
6 |
|
diffusion tensor imaging |
6 |
|
dna mutational analysis - methods |
6 |
|
educational status |
6 |
|
exons - genetics |
6 |
|
familial amyotrophic lateral sclerosis |
6 |
|
fiber tracking |
6 |
|
ich volume |
6 |
|
intraventricular extension |
6 |
|
isoleucine - genetics |
6 |
|
mediterranean-style diet |
6 |
|
mutations |
6 |
|
nerve fibers, myelinated - pathology |
6 |
|
neurological deterioration |
6 |
|
pedigree |
6 |
|
phenotype |
6 |
|
repetitive transcranial magnetic stimulation |
6 |
|
retrogenesis |
6 |
|
reverse transcriptase polymerase chain reaction - methods |
6 |
|
sod1 |
6 |
|
superoxide dismutase - genetics |
6 |
|
threonine - genetics |
6 |
|
vascular endothelial growth factor a - genetics |
6 |
|
vegf |
6 |
|
visit-to-visit blood pressure variability |
6 |
|
warfarin |
6 |
|
warfarin-associated ich |
6 |
|
white matter integrity |
6 |
|
acupuncture |
5 |
|
cerebral angiography |
5 |
|
chinese |
5 |
|
cross-sectional studies |
5 |
|
dysphagia |
5 |
|
epidemiology |
5 |
|
fatal outcome |
5 |
|
fmri |
5 |
|
follow-up |
5 |
|
hong kong |
5 |
|
incidence |
5 |
|
intracranial hemorrhage |
5 |
|
motor neuron disease |
5 |
|
myocardial infarction |
5 |
|
neurorehabilitation |
5 |
|
rat |
5 |
|
rats |
5 |
|
rats, sprague-dawley |
5 |
|
risk factors |
5 |
|
secondary prevention |
5 |
|
treatment outcome |
5 |
|
acupuncture points |
4 |
|
age factors |
4 |
|
amyotrophic lateral sclerosis |
4 |
|
angiography, digital subtraction |
4 |
|
animal model |
4 |
|
biomarker |
4 |
|
brain edema - etiology |
4 |
|
brain ischemia - physiopathology |
4 |
|
caveolin 1 - metabolism |
4 |
|
caveolin-1 |
4 |
|
cerebrovascular circulation |
4 |
|
cervical vertebrae |
4 |
|
chi-square distribution |
4 |
|
cognitive dysfunction |
4 |
|
coronavirus disease |
4 |
|
depression |
4 |
|
dermatomyositis - etiology - therapy |
4 |
|
diffusion tensor magnetic resonance imaging |
4 |
|
education |
4 |
|
electrophysiological studies |
4 |
|
enzyme inhibitors - pharmacology |
4 |
|
epidemiologic studies |
4 |
|
fever of unknown origin - microbiology - radiography |
4 |
|
gene expression regulation - drug effects |
4 |
|
hand - physiopathology |
4 |
|
hematoma aspiration |
4 |
|
hong kong - epidemiology |
4 |
|
infant |
4 |
|
infarction, middle cerebral artery - complications - diagnosis - physiopathology |
4 |
|
inhibition |
4 |
|
internal capsule - pathology |
4 |
|
intralesional injection |
4 |
|
lymphatic metastasis |
4 |
|
magnetic resonance imaging - methods |
4 |
|
magnetic stimulation |
4 |
|
mesencephalon - pathology |
4 |
|
motor neuron disease - diagnosis - epidemiology |
4 |
|
motor neuron disease - etiology - therapy |
4 |
|
movement |
4 |
|
myositis - etiology - therapy |
4 |
|
nasopharyngeal carcinoma |
4 |
|
nasopharyngeal neoplasms - complications |
4 |
|
neoplasm recurrence, local - complications - therapy |
4 |
|
nervous system - physiopathology |
4 |
|
neural activation |
4 |
|
neuromotor outcome |
4 |
|
neuropsychiatric lupus |
4 |
|
ng-nitroarginine methyl ester - pharmacology |
4 |
|
nitric oxide |
4 |
|
nitric oxide - physiology |
4 |
|
nitric oxide donors - pharmacology |
4 |
|
nitric oxide synthase |
4 |
|
nitric oxide synthase - antagonists & inhibitors |
4 |
|
ornithine - analogs & derivatives - pharmacology |
4 |
|
p300 |
4 |
|
paediatric infarction |
4 |
|
paraneoplastic inflammatory myopathy |
4 |
|
paraneoplastic motor neuropathy |
4 |
|
paraneoplastic syndromes - etiology - therapy |
4 |
|
paresis - etiology - physiopathology |
4 |
|
photic stimulation |
4 |
|
post-stroke dysphagia |
4 |
|
pregnancy |
4 |
|
pregnancy complications, infectious - etiology - radiography |
4 |
|
prevalence |
4 |
|
processing speed |
4 |
|
prospective memory |
4 |
|
prospective memory interference |
4 |
|
prospective studies |
4 |
|
psychiatry and neurology |
4 |
|
public health |
4 |
|
pyramidal tracts - pathology |
4 |
|
reading |
4 |
|
reperfusion injury - physiopathology |
4 |
|
retrospective studies |
4 |
|
sex factors |
4 |
|
silent picture-naming task |
4 |
|
silent word recognition task |
4 |
|
socioeconomic factors |
4 |
|
substance abuse, intravenous - complications |
4 |
|
tomography, x-ray computed - methods |
4 |
|
tuberculoma - complications - radiography |
4 |
|
tuberculosis, meningeal - complications - radiography |
4 |
|
visual perception - physiology |
4 |
|
wallerian degeneration |
4 |
|
wallerian degeneration - diagnosis - etiology |
4 |
|
acetylcholine receptor autoantibodies |
3 |
|
acute disease |
3 |
|
acute disseminated encephalomyelitis |
3 |
|
acute transverse myelitis |
3 |
|
affective symptoms - etiology |
3 |
|
age of onset |
3 |
|
ageing |
3 |
|
aging - physiology |
3 |
|
analgesics - adverse effects - therapeutic use |
3 |
|
analysis of variance |
3 |
|
anti-coagulation |
3 |
|
anti-infective agents - administration & dosage - adverse effects |
3 |
|
anti-inflammatory agents - therapeutic use |
3 |
|
anticoagulants - therapeutic use |
3 |
|
anticonvulsants - adverse effects - therapeutic use |
3 |
|
antihypertensive agents - adverse effects - pharmacology - therapeutic use |
3 |
|
antioxidants - metabolism |
3 |
|
antiparkinson agents - therapeutic use |
3 |
|
antitubercular agents - therapeutic use |
3 |
|
antiviral agents - therapeutic use |
3 |
|
asian continental ancestry group - psychology |
3 |
|
asian continental ancestry group - statistics & numerical data |
3 |
|
autoantibodies - blood |
3 |
|
bath-related headache |
3 |
|
baths - adverse effects |
3 |
|
benign paroxysmal positional vertigo |
3 |
|
biological evolution |
3 |
|
bone marrow transplantation |
3 |
|
bone marrow transplantation - adverse effects |
3 |
|
brain - blood supply |
3 |
|
brain - blood supply - physiology |
3 |
|
brain - pathology - virology |
3 |
|
brain diseases - diagnosis |
3 |
|
brain ischemia - etiology - physiopathology |
3 |
|
brain neoplasms - complications - pathology - secondary |
3 |
|
brainstem |
3 |
|
bromocriptine - therapeutic use |
3 |
|
carcinoma, non-small-cell lung - complications - pathology - secondary |
3 |
|
carotid arteries - pathology |
3 |
|
carotid artery diseases |
3 |
|
carotid artery, internal - radiography |
3 |
|
cerebral arteries |
3 |
|
cerebral arteries - metabolism |
3 |
|
cerebral haemorrhage |
3 |
|
cerebral infarction |
3 |
|
cerebral infarction - etiology - radiography |
3 |
|
cerebral microbleeds |
3 |
|
cerebral venous thrombosis |
3 |
|
chelating agents - therapeutic use |
3 |
|
china - ethnology |
3 |
|
chinese reading |
3 |
|
chronic graft versus host disease |
3 |
|
ciprofloxacin - administration & dosage - adverse effects |
3 |
|
classical multiple sclerosis |
3 |
|
compute tomography |
3 |
|
confusion - etiology |
3 |
|
coronary artery disease vertebral artery |
3 |
|
coronary disease - pathology |
3 |
|
corticosteroid |
3 |
|
ct |
3 |
|
demyelinating diseases - diagnosis - etiology - therapy |
3 |
|
demyelinating disorders |
3 |
|
depression - ethnology - psychology - rehabilitation |
3 |
|
depression after stroke |
3 |
|
depression literacy |
3 |
|
depressive disorder - complications - pathology - psychology |
3 |
|
dexamethasone - therapeutic use |
3 |
|
diabetes complications - etiology |
3 |
|
digital subtraction angiography |
3 |
|
diphenhydramine - therapeutic use |
3 |
|
disease progression |
3 |
|
dyskinesia, drug-induced - etiology - therapy |
3 |
|
earache - etiology |
3 |
|
early-onset myasthneia gravis |
3 |
|
elderly |
3 |
|
electric stimulation |
3 |
|
emphysema |
3 |
|
encephalitis, herpes simplex - pathology |
3 |
|
encephalomyelitis, acute disseminated - diagnosis - etiology - virology |
3 |
|
environment |
3 |
|
epilepsy, generalized - etiology |
3 |
|
equipment design |
3 |
|
european continental ancestry group - genetics |
3 |
|
evoked potentials, motor - physiology |
3 |
|
expand disability status scale |
3 |
|
face |
3 |
|
fever - etiology |
3 |
|
fibrosis |
3 |
|
follow-up studies |
3 |
|
forced expiratory volume |
3 |
|
frontal lobe - pathology |
3 |
|
function silicosis |
3 |
|
functional magnetic resonance imaging |
3 |
|
gamma-aminobutyric acid - adverse effects - analogs & derivatives - therapeutic use |
3 |
|
gene expression regulation, developmental - genetics |
3 |
|
glaucoma - diagnosis |
3 |
|
graft vs host disease - virology |
3 |
|
guillain-barre syndrome |
3 |
|
guillain-barré syndrome |
3 |
|
habitual response |
3 |
|
headache |
3 |
|
headache - diagnosis - etiology - therapy |
3 |
|
headache - etiology |
3 |
|
health knowledge, attitudes, practice |
3 |
|
heparin, low-molecular-weight - therapeutic use |
3 |
|
hepatitis e |
3 |
|
hepatitis e virus |
3 |
|
hepatolenticular degeneration - complications - pathology - psychology |
3 |
|
hereditary sensory and autonomic neuropathies - blood - diagnosis |
3 |
|
hereditary sensory and motor neuropathy - blood - diagnosis |
3 |
|
histamine h1 antagonists - therapeutic use |
3 |
|
hong kong - ethnology |
3 |
|
hypertension - complications - drug therapy |
3 |
|
idiopathic inflammatory |
3 |
|
idiopathic transverse myelitis |
3 |
|
image processing, computer-assisted |
3 |
|
image processing, computer-assisted - methods |
3 |
|
infarction, middle cerebral artery - etiology - physiopathology - radiography - surgery |
3 |
|
infarction, posterior cerebral artery - etiology - physiopathology |
3 |
|
intelligence - genetics |
3 |
|
intracranial arteriosclerosis - complications |
3 |
|
intracranial arteriosclerosis - genetics |
3 |
|
intracranial hemorrhages - etiology - pathology - physiopathology |
3 |
|
intracranial thrombosis - complications |
3 |
|
intracranial thrombosis - complications - pathology - physiopathology |
3 |
|
language |
3 |
|
large artery infarct |
3 |
|
late-onset myasthenia gravis |
3 |
|
leukemia, myeloid, acute - drug therapy |
3 |
|
life style |
3 |
|
lung |
3 |
|
lung - physiopathology - radiography |
3 |
|
lung neoplasms - complications - pathology |
3 |
|
lupus erythematosus, systemic - blood - complications |
3 |
|
melatonin |
3 |
|
meningeal neoplasms - drug therapy |
3 |
|
mental health |
3 |
|
middle cerebral artery - radiography |
3 |
|
minimally conscious state |
3 |
|
models, biological |
3 |
|
motor endplate - metabolism |
3 |
|
multiple sclerosis |
3 |
|
muscle, skeletal - metabolism |
3 |
|
myasthenia gravis - diagnosis - epidemiology - therapy |
3 |
|
myelin sheath - pathology |
3 |
|
myelitis, transverse - complications - diagnosis - physiopathology - therapy |
3 |
|
myelitis, transverse - diagnosis - etiology - therapy |
3 |
|
myopia - genetics |
3 |
|
nephrotic syndrome - complications |
3 |
|
neuroimaging |
3 |
|
neuromyelitis optica |
3 |
|
neuropsychological assessment |
3 |
|
neuropsychological tests - statistics & numerical data |
3 |
|
nonthymoma-generalized myasthenia gravis |
3 |
|
older adults |
3 |
|
opportunistic infections - etiology - virology |
3 |
|
oriental female |
3 |
|
outcome |
3 |
|
oxygen - blood |
3 |
|
para-influenza virus |
3 |
|
parainfluenza virus 3, human |
3 |
|
parkinsonian disorders - complications - pathology - psychology |
3 |
|
parkinsonism |
3 |
|
penicillamine |
3 |
|
penicillamine - therapeutic use |
3 |
|
plasmapheresis |
3 |
|
porcine liver |
3 |
|
psychiatry and neurology medical sciences |
3 |
|
psychomotor performance - physiology |
3 |
|
pulmonary |
3 |
|
pulmonary diffusing capacity - physiology |
3 |
|
pulmonary edema - etiology |
3 |
|
pulmonary emphysema - physiopathology - radiography |
3 |
|
pulmonary fibrosis - physiopathology - radiography |
3 |
|
pyelonephritis - drug therapy |
3 |
|
questionnaires |
3 |
|
radiography, interventional |
3 |
|
radiography, thoracic |
3 |
|
reaction time - physiology |
3 |
|
receptors, nicotinic - immunology |
3 |
|
recurrence |
3 |
|
respirovirus infections - etiology |
3 |
|
response regulation |
3 |
|
seizures - etiology |
3 |
|
selection, genetic |
3 |
|
severity of illness index |
3 |
|
silent lacunes |
3 |
|
silicosis - physiopathology - radiography |
3 |
|
smoking |
3 |
|
spinal cord |
3 |
|
standard deviation |
3 |
|
striated muscle autoantibodies |
3 |
|
stroke - complications |
3 |
|
stroke - ethnology - psychology - rehabilitation |
3 |
|
suicide, attempted |
3 |
|
surgery |
3 |
|
systemic lupus erythematosus (sle) |
3 |
|
temporal lobe - pathology |
3 |
|
thrombectomy - instrumentation - methods |
3 |
|
thunderclap headache |
3 |
|
transplantation, homologous - adverse effects |
3 |
|
trientine - therapeutic use |
3 |
|
trientine hydrochloride |
3 |
|
triggering agents |
3 |
|
trihexyphenidyl - therapeutic use |
3 |
|
trismus - chemically induced |
3 |
|
tuberculoma, intracranial - diagnosis |
3 |
|
tuberculosis, meningeal - complications - drug therapy - radiography |
3 |
|
tuberculous meningitis |
3 |
|
vascular cognitive impairment |
3 |
|
vasoconstriction |
3 |
|
venous thrombosis - complications |
3 |
|
venous thrombosis - complications - pathology - physiopathology |
3 |
|
vertebral artery - pathology |
3 |
|
viral encephalitis |
3 |
|
vision disorders - etiology |
3 |
|
vital capacity |
3 |
|
warfarin - therapeutic use |
3 |
|
wernicke encephalopathy - complications - diagnosis |
3 |
|
white matter hyperintensities |
3 |
|
wilson's disease |
3 |
|
abducens nerve diseases - etiology |
2 |
|
activities of daily living |
2 |
|
acupoint |
2 |
|
acupucture |
2 |
|
acupuncture therapy |
2 |
|
acupuncture, fmri |
2 |
|
alzheimer |
2 |
|
ambulatory care - economics |
2 |
|
amyotrophic lateral sclerosis - diagnosis |
2 |
|
angiography |
2 |
|
angioplasty |
2 |
|
angioplasty, balloon |
2 |
|
antibodies, monoclonal - administration & dosage - therapeutic use |
2 |
|
antibodies, viral - analysis |
2 |
|
anticonvulsants - therapeutic use |
2 |
|
antiplatelet |
2 |
|
aphasia |
2 |
|
aphasia - etiology - psychology - radiography - therapy |
2 |
|
atherosclerosis |
2 |
|
biochemistry |
2 |
|
blood cell count |
2 |
|
blood glucose |
2 |
|
blood glucose - analysis |
2 |
|
blood pressure - drug effects |
2 |
|
body temperature - drug effects |
2 |
|
body weight - drug effects |
2 |
|
brain - drug effects |
2 |
|
brain ischemia - complications - pathology |
2 |
|
brain ischemia - prevention & control |
2 |
|
brain stem neoplasms - diagnosis - secondary |
2 |
|
bulbar palsy, progressive - diagnosis |
2 |
|
carcinoma, adenosquamous - complications - diagnosis |
2 |
|
carotid artery disease |
2 |
|
carotid artery stenosis |
2 |
|
carotid artery, common - surgery |
2 |
|
carotid artery, internal - physiopathology - surgery |
2 |
|
carotid stenosis - diagnosis - physiopathology - surgery |
2 |
|
cell death |
2 |
|
cell proliferation |
2 |
|
cerebral arteries - pathology |
2 |
|
cerebral cortex |
2 |
|
cerebral hyperperfusion injury |
2 |
|
cerebral infarction - pathology |
2 |
|
cerebral tuberculoma |
2 |
|
cerebral veins |
2 |
|
cerebrospinal fluid |
2 |
|
cerebrospinal fluid - chemistry |
2 |
|
cerebrovascular disorders - etiology - physiopathology - prevention & control - therapy |
2 |
|
china - epidemiology |
2 |
|
chinese medicine |
2 |
|
chronic stroke |
2 |
|
circadian rhythm |
2 |
|
circadian rhythm - physiology |
2 |
|
cost of epilepsy |
2 |
|
cost-of-illness |
2 |
|
data collection |
2 |
|
demyelinating-diseases-chemically-induced |
2 |
|
depression - diagnosis - etiology |
2 |
|
depression after stroke (das) |
2 |
|
detection |
2 |
|
diagnostic approach |
2 |
|
diazepam - therapeutic use |
2 |
|
disability evaluation |
2 |
|
drug evaluation, preclinical |
2 |
|
drug toxicity |
2 |
|
drug- induced hepatotoxicity |
2 |
|
electro-acupuncture |
2 |
|
electroacupuncture |
2 |
|
electroencephalography |
2 |
|
epilepsy |
2 |
|
epilepsy - economics - rehabilitation |
2 |
|
epilepsy - etiology - physiopathology |
2 |
|
epilepsy, generalized |
2 |
|
epilepsy, reflex |
2 |
|
epilepsy, reflex - etiology |
2 |
|
event-related potential (erp) |
2 |
|
extremities - physiology |
2 |
|
foot - innervation - physiology |
2 |
|
frontal lobe - anatomy & histology - physiology |
2 |
|
functional deficits |
2 |
|
gambling |
2 |
|
geriatric depression scale (gds) |
2 |
|
glial fibrillary acidic protein |
2 |
|
glucose - metabolism |
2 |
|
glucose/cerebrospinal fluid |
2 |
|
go/nogo |
2 |
|
health care costs - statistics & numerical data - trends |
2 |
|
health services - standards - supply & distribution |
2 |
|
heart rate - drug effects |
2 |
|
hematology |
2 |
|
hemodynamics |
2 |
|
hexanes-toxicity |
2 |
|
histology |
2 |
|
hiv - immunology |
2 |
|
hospitalization - economics |
2 |
|
hospitals |
2 |
|
hospitals, public - economics |
2 |
|
hospitals, urban |
2 |
|
hydrocephalus - cerebrospinal fluid - drug therapy - etiology |
2 |
|
immunoglobulin fab fragments - administration & dosage - therapeutic use |
2 |
|
in vivo |
2 |
|
infarct |
2 |
|
infarction |
2 |
|
injections, intra-arterial |
2 |
|
injections, intravenous |
2 |
|
intracerebral haemorrhage |
2 |
|
intracranial arterial disease |
2 |
|
intracranial thrombosis - diagnosis - epidemiology - etiology |
2 |
|
intraoperative complications - prevention & control |
2 |
|
ischaemic stroke |
2 |
|
ischemia-reperfusion |
2 |
|
ischemic attack, transient - mortality - physiopathology |
2 |
|
ischemic cerebrovascular event |
2 |
|
knowledge |
2 |
|
language tests |
2 |
|
length of stay |
2 |
|
leptomeningeal metastasis |
2 |
|
map kinase |
2 |
|
mca |
2 |
|
melatonin - administration & dosage - adverse effects - blood - pharmacokinetics |
2 |
|
memory test |
2 |
|
meningeal neoplasms - diagnosis - secondary |
2 |
|
meningitis - diagnosis - etiology |
2 |
|
middle cerebral artery - pathology |
2 |
|
middle cerebral artery occlusion |
2 |
|
motor cortex - physiology |
2 |
|
motor neuron disease - diagnosis - epidemiology - mortality |
2 |
|
motor recovery |
2 |
|
mycobacterium tuberculosis - isolation & purification |
2 |
|
nanomaterial |
2 |
|
neoplasms, unknown primary |
2 |
|
nerve-degeneration-drug-effects |
2 |
|
nervous system -- diseases -- diagnosis. |
2 |
|
nervous system -- diseases -- treatment. |
2 |
|
nervous system -- diseases. |
2 |
|
nervous system diseases - complications |
2 |
|
nervous system diseases - diagnosis |
2 |
|
neural responses |
2 |
|
neurology. |
2 |
|
neuroprotective |
2 |
|
occipital lobe - anatomy & histology - physiology |
2 |
|
oddball |
2 |
|
pharmacokinetics |
2 |
|
plaque, atherosclerotic - pathology |
2 |
|
platelet aggregation inhibitors - administration & dosage - therapeutic use |
2 |
|
platelet aggregation inhibitors - therapeutic use |
2 |
|
pons |
2 |
|
postoperative complications - physiopathology |
2 |
|
predictors |
2 |
|
printing- |
2 |
|
propylene glycol |
2 |
|
prospective memory (pm) |
2 |
|
psychiatry and neurology gerontology and geriatrics |
2 |
|
psychomotor performance |
2 |
|
recovery of function |
2 |
|
recreation |
2 |
|
reference values |
2 |
|
rehabilitation |
2 |
|
remission, spontaneous |
2 |
|
rose bengal |
2 |
|
seizures - etiology - physiopathology |
2 |
|
self-assembling peptide nanofiber scaffold |
2 |
|
sensitivity and specificity |
2 |
|
sensorimotor |
2 |
|
sensorimotor cortex |
2 |
|
somatosensory cortex - physiology |
2 |
|
spinal puncture |
2 |
|
status epilepticus - diagnosis - drug therapy - physiopathology |
2 |
|
stenting |
2 |
|
stents |
2 |
|
stroke - complications - psychology - radiography - therapy |
2 |
|
stroke - epidemiology - physiopathology - rehabilitation |
2 |
|
stroke - etiology - pathology |
2 |
|
stroke - mortality - physiopathology |
2 |
|
stroke - prevention & control |
2 |
|
stroke assessment |
2 |
|
stroke classification |
2 |
|
stroke mechanism |
2 |
|
stroke onset |
2 |
|
subacute stroke |
2 |
|
substance-related disorders - complications |
2 |
|
survey |
2 |
|
temporal lobe - anatomy & histology - physiology |
2 |
|
temporal lobe epilepsy (tle) |
2 |
|
thrombolytic |
2 |
|
time factors |
2 |
|
tomography, emission-computed, single-photon |
2 |
|
transient ischaemic attack |
2 |
|
tuberculosis, meningeal - cerebrospinal fluid - complications - drug therapy |
2 |
|
tuberculosis, meningeal - diagnosis - drug therapy - epidemiology |
2 |
|
urban population |
2 |
|
urinary incontinence - epidemiology - physiopathology - rehabilitation |
2 |
|
venous thrombosis - diagnosis - epidemiology - etiology |
2 |
|
vision |
2 |
|
visual activation |
2 |
|
visual cortex |
2 |
|
visual cortex - anatomy & histology - physiology |
2 |
|
visual screening tool |
2 |
|
word-generation |
2 |
|
working memory |
2 |
|
2,3,5-triphenyltetrazolium chloride |
1 |
|
abnormalities, multiple - ethnology |
1 |
|
abscess - microbiology - radiography |
1 |
|
activated factor vii |
1 |
|
acute stroke |
1 |
|
adie syndrome - diagnosis - physiopathology |
1 |
|
adie's pupil |
1 |
|
adjuvants, immunologic - adverse effects |
1 |
|
age distribution |
1 |
|
air-jet stimulation |
1 |
|
amygdala |
1 |
|
amygdala - blood supply - metabolism |
1 |
|
amygdala - chemistry - drug effects - metabolism |
1 |
|
amygdala - drug effects - metabolism |
1 |
|
amygdala - metabolism - pathology |
1 |
|
amygdala - physiopathology |
1 |
|
aneurysm, dissecting - pathology - radiography |
1 |
|
angiogenesis |
1 |
|
anti-anxiety agents - administration & dosage - pharmacology |
1 |
|
anti-anxiety agents - pharmacology |
1 |
|
anti-apoptosis |
1 |
|
anti-inflammatory |
1 |
|
antibodies, monoclonal - adverse effects |
1 |
|
anticoagulants - adverse effects |
1 |
|
antimetabolites, antineoplastic - adverse effects |
1 |
|
antineoplastic combined chemotherapy protocols - adverse effects |
1 |
|
antioxidant |
1 |
|
antioxidants - pharmacology |
1 |
|
antiplatyhelmintic agents - adverse effects - therapeutic use |
1 |
|
antisense oligodeoxynucleotide |
1 |
|
areflexia |
1 |
|
arginine - administration & dosage - analogs & derivatives - pharmacology |
1 |
|
arginine - analogs & derivatives - pharmacology |
1 |
|
arrhythmias, cardiac - complications |
1 |
|
arrhythmias, cardiac - complications - physiopathology - therapy |
1 |
|
arterial occlusive diseases - diagnosis - etiology |
1 |
|
arterial occlusive diseases - metabolism |
1 |
|
arterial occlusive diseases - physiopathology |
1 |
|
arterial occlusive diseases - surgery - ultrasonography |
1 |
|
asia - epidemiology |
1 |
|
aspirin - therapeutic use |
1 |
|
astrocytes |
1 |
|
astrocytes - drug effects - pathology |
1 |
|
astrocytes - metabolism |
1 |
|
atrial fibrillation |
1 |
|
atrial fibrillation - complications |
1 |
|
atrial fibrillation - drug therapy |
1 |
|
autonomic nervous system - pathology |
1 |
|
autonomic nervous system diseases - etiology |
1 |
|
axonal transport - drug effects |
1 |
|
balloon dilation |
1 |
|
basilar artery |
1 |
|
basilar artery - abnormalities |
1 |
|
bibp3226 |
1 |
|
blink reflex |
1 |
|
blood flow velocity |
1 |
|
blood pressure - drug effects - physiology |
1 |
|
blood pressure - genetics |
1 |
|
blood pressure - physiology |
1 |
|
blood-brain barrier |
1 |
|
brain - blood supply - drug effects |
1 |
|
brain - blood supply - drug effects - pathology |
1 |
|
brain - drug effects - metabolism - pathology |
1 |
|
brain - drug effects - pathology - physiopathology |
1 |
|
brain - metabolism - pathology |
1 |
|
brain - physiopathology |
1 |
|
brain chemistry - physiology |
1 |
|
brain diseases - microbiology - radiography |
1 |
|
brain edema - pathology |
1 |
|
brain ischemia |
1 |
|
brain ischemia - complications - physiopathology |
1 |
|
brain ischemia - metabolism |
1 |
|
brain ischemia - metabolism - pathology |
1 |
|
brain ischemia - pathology |
1 |
|
brain ischemia - pathology - radiography - surgery |
1 |
|
brain ischemia - physiopathology - radiography - radionuclide imaging |
1 |
|
brain ischemia - physiopathology - ultrasonography |
1 |
|
brain neoplasms - diagnosis - physiopathology - radiography |
1 |
|
brain stem - metabolism - pathology |
1 |
|
cantonese |
1 |
|
cardiac catheterization |
1 |
|
cardiac surgery |
1 |
|
cardiac susceptibility |
1 |
|
cardio-embolism |
1 |
|
cardiomyopathies - etiology - therapy |
1 |
|
carotid arteries - surgery - ultrasonography |
1 |
|
carotid artery, internal |
1 |
|
carotid endarterectomy |
1 |
|
carotid stenosis |
1 |
|
carotid stenosis - diagnosis - physiopathology |
1 |
|
carotid stenosis - epidemiology - surgery |
1 |
|
carotid stenosis - therapy |
1 |
|
carotid stenosis - ultrasonography |
1 |
|
cause of death |
1 |
|
cell culture |
1 |
|
cell death - drug effects |
1 |
|
cell hypoxia - drug effects |
1 |
|
cell line |
1 |
|
cell survival |
1 |
|
cells, cultured |
1 |
|
central nervous system diseases - drug therapy |
1 |
|
cerebral arteries - physiology |
1 |
|
cerebral arteries - physiopathology |
1 |
|
cerebral blood flow |
1 |
|
cerebral cortex - anatomy and histology - pathology |
1 |
|
cerebral cortex - chemistry - drug effects - metabolism |
1 |
|
cerebral cortex - drug effects - metabolism |
1 |
|
cerebral cortex - metabolism |
1 |
|
cerebral cortex - pathology |
1 |
|
cerebral cortex - physiopathology |
1 |
|
cerebral cortical response |
1 |
|
cerebral hemorrhage |
1 |
|
cerebral hemorrhage - chemically induced - complications |
1 |
|
cerebral hemorrhage - classification - diagnosis - mortality |
1 |
|
cerebral hemorrhage - complications - physiopathology |
1 |
|
cerebral hemorrhage - diagnosis - epidemiology |
1 |
|
cerebral hemorrhage - drug therapy |
1 |
|
cerebral hemorrhage - drug therapy - etiology - surgery |
1 |
|
cerebral hemorrhage - etiology |
1 |
|
cerebral hemorrhage - pathology |
1 |
|
cerebral hemorrhage - pathology - physiopathology - radiography - radionuclide imaging |
1 |
|
cerebral hemorrhage - physiopathology - ultrasonography |
1 |
|
cerebral infarction - blood - drug therapy - mortality |
1 |
|
cerebral infarction - complications - drug therapy |
1 |
|
cerebral infarction - complications - drug therapy - pathology - physiopathology |
1 |
|
cerebral infarction - diagnosis |
1 |
|
cerebral infarction - diagnosis - physiopathology - radiography |
1 |
|
cerebral infarction - drug therapy - pathology - physiopathology |
1 |
|
cerebral infarction - etiology - pathology |
1 |
|
cerebral infarction - etiology - pathology - prevention & control |
1 |
|
cerebral infarction - etiology - physiopathology |
1 |
|
cerebral infarction - pathology - physiopathology |
1 |
|
cerebral ischaemia |
1 |
|
cerebral ischemia |
1 |
|
cerebrovascular accident |
1 |
|
cerebrovascular accident - diagnosis - therapy |
1 |
|
cerebrovascular accident - therapy |
1 |
|
cerebrovascular circulation - drug effects |
1 |
|
cerebrovascular circulation - drug effects - physiology |
1 |
|
cerebrovascular circulation - genetics |
1 |
|
cerebrovascular disorders |
1 |
|
cerebrovascular disorders - diagnosis |
1 |
|
cerebrovascular disorders - epidemiology |
1 |
|
cerebrovascular disorders - etiology |
1 |
|
cerebrovascular disorders - etiology - physiopathology - therapy |
1 |
|
cerebrovascular disorders - therapy |
1 |
|
clinical protocols |
1 |
|
clinical trials |
1 |
|
coagulants - therapeutic use |
1 |
|
cohort studies |
1 |
|
colchicine - pharmacology |
1 |
|
colonic neoplasms - drug therapy |
1 |
|
coloring agents - pharmacology |
1 |
|
comorbidity |
1 |
|
computed tomography |
1 |
|
computer gaming |
1 |
|
constipation |
1 |
|
contrast media - administration & dosage |
1 |
|
cranial nerves |
1 |
|
craniotomy |
1 |
|
cyclooxygenase |
1 |
|
cyclooxygenase 1 |
1 |
|
cyclooxygenase 1 - genetics |
1 |
|
cyclooxygenase 2 |
1 |
|
cyclooxygenase-1 |
1 |
|
cyclooxygenase-2 |
1 |
|
cysticercosis - drug therapy |
1 |
|
d |
1 |
|
death, sudden |
1 |
|
dementia, vascular - chemically induced - drug therapy |
1 |
|
diabetes |
1 |
|
diabetes mellitus |
1 |
|
diastole |
1 |
|
diffusion |
1 |
|
diffusion-weighted magnetic resonance imaging |
1 |
|
disability |
1 |
|
disabled persons - psychology |
1 |
|
disease models, animal |
1 |
|
disease-free survival |
1 |
|
dose-response |
1 |
|
dose-response relationship, drug |
1 |
|
double-blind method |
1 |
|
drug administration schedule |
1 |
|
dynorphin |
1 |
|
dynorphins - analysis - metabolism |
1 |
|
dynorphins - metabolism |
1 |
|
dynorphins - pharmacology |
1 |
|
early surgery |
1 |
|
eclampsia |
1 |
|
electrocardiography |
1 |
|
electron paramagnetic resonance |
1 |
|
electron spin resonance spectroscopy |
1 |
|
electrophysiology |
1 |
|
endarterectomy |
1 |
|
endarterectomy, carotid |
1 |
|
endarterectomy, carotid - statistics & numerical data |
1 |
|
endogenous opioids |
1 |
|
enkephalin, leucine - analysis - metabolism |
1 |
|
enkephalin, leucine - metabolism |
1 |
|
enkephalin, leucine - pharmacology |
1 |
|
epidermal growth factor - administration and dosage - pharmacology |
1 |
|
epilepsy - chemically induced |
1 |
|
epilepsy/drug therapy |
1 |
|
evans blue |
1 |
|
exercise |
1 |
|
eye fixations |
1 |
|
facial paralysis |
1 |
|
factor viia - therapeutic use |
1 |
|
fast fourier transformation |
1 |
|
fluorouracil - adverse effects |
1 |
|
focal cerebral ischemia |
1 |
|
focal ischemia |
1 |
|
forecasting |
1 |
|
fourier analysis |
1 |
|
free radical scavengers - pharmacology |
1 |
|
free radicals |
1 |
|
galactose - administration & dosage - diagnostic use |
1 |
|
gene knockout |
1 |
|
glasgow coma scale |
1 |
|
glasgow coma scale - statistics & numerical data |
1 |
|
glial fibrillary acidic protein - metabolism |
1 |
|
glucose - deficiency |
1 |
|
glycerin |
1 |
|
glycerol - administration & dosage - adverse effects |
1 |
|
glycerol - adverse effects - therapeutic use |
1 |
|
headache - epidemiology - etiology |
1 |
|
health behavior |
1 |
|
health education |
1 |
|
health education - statistics & numerical data |
1 |
|
heart - physiopathology |
1 |
|
heart diseases - complications |
1 |
|
heart rate - drug effects - physiology |
1 |
|
heart rate - physiology |
1 |
|
heart rate variability |
1 |
|
hematoma - diagnosis - epidemiology |
1 |
|
hematoma - etiology |
1 |
|
hemodynamics - drug effects |
1 |
|
hemoglobinuria - chemically induced |
1 |
|
hemolysis |
1 |
|
heparin, low-molecular-weight - adverse effects |
1 |
|
heroin dependence - complications |
1 |
|
holmes-adie syndrome |
1 |
|
hospital mortality |
1 |
|
hospitalization |
1 |
|
hypertension - complications - drug therapy - metabolism - pathology |
1 |
|
hypertension - complications - therapy |
1 |
|
hypertension - pathology - physiopathology |
1 |
|
immunoglobulin fab fragments - adverse effects |
1 |
|
immunoglobulins - therapeutic use |
1 |
|
immunohistochemistry |
1 |
|
in vitro |
1 |
|
induced motions |
1 |
|
infarct volume |
1 |
|
infarction, middle cerebral artery - complications - drug therapy - pathology |
1 |
|
infarction, middle cerebral artery - drug therapy - metabolism |
1 |
|
infarction, middle cerebral artery - drug therapy - metabolism - pathology |
1 |
|
infarction, middle cerebral artery - drug therapy - pathology - physiopathology |
1 |
|
infarction, middle cerebral artery - drug therapy - pathology - prevention & control |
1 |
|
infarction, middle cerebral artery - enzymology - genetics |
1 |
|
infarction, middle cerebral artery - mortality - radiography |
1 |
|
infarction, middle cerebral artery - pathology - radiography |
1 |
|
infarction, middle cerebral artery - physiopathology - prevention & control |
1 |
|
infarction, middle cerebral artery - physiopathology - ultrasonography |
1 |
|
infective endocarditis |
1 |
|
inflammation |
1 |
|
injections, intraperitoneal |
1 |
|
injections, intraventricular |
1 |
|
injections, spinal |
1 |
|
insular cortex |
1 |
|
intermediate filament proteins - metabolism |
1 |
|
intracranial embolism - ultrasonography |
1 |
|
intracranial embolism and thrombosis - ultrasonography |
1 |
|
intracranial hemorrhages - epidemiology - mortality |
1 |
|
intracranial hypertension - diagnosis - prevention & control |
1 |
|
ischaemic heart disease |
1 |
|
ischemia |
1 |
|
ischemia/reperfusion injury |
1 |
|
ischemic attack, transient - complications - drug therapy - pathology |
1 |
|
ischemic attack, transient - diagnosis |
1 |
|
ischemic attack, transient - diagnosis - etiology |
1 |
|
ischemic attack, transient - diagnosis - therapy |
1 |
|
ischemic attack, transient - metabolism |
1 |
|
ischemic attack, transient - therapy |
1 |
|
ischemic attack, transient - ultrasonography |
1 |
|
isoenzymes - deficiency - genetics - physiology |
1 |
|
isoenzymes - metabolism |
1 |
|
knockout |
1 |
|
laser-doppler flowmetry |
1 |
|
leucine‐enkephalin |
1 |
|
levamisole - adverse effects |
1 |
|
libido |
1 |
|
logistic models |
1 |
|
l‐homocysteic acid |
1 |
|
magnetic resonance angiography |
1 |
|
mandarin |
1 |
|
mcao |
1 |
|
melatonin - administration & dosage |
1 |
|
melatonin - administration & dosage - therapeutic use |
1 |
|
melatonin - pharmacokinetics - pharmacology |
1 |
|
melatonin - pharmacology |
1 |
|
melatonin receptor |
1 |
|
membrane proteins |
1 |
|
mental disorders - pathology - physiopathology - prevention and control |
1 |
|
mice |
1 |
|
mice, inbred c57bl |
1 |
|
mice, knockout |
1 |
|
microbleeds |
1 |
|
microinjections |
1 |
|
migraine |
1 |
|
migraine disorders - diagnosis - epidemiology |
1 |
|
migraine disorders - epidemiology |
1 |
|
monitoring, intraoperative - methods |
1 |
|
motor skills |
1 |
|
multicenter studies as topic - statistics & numerical data |
1 |
|
multivariate analysis |
1 |
|
myeloperoxidase |
1 |
|
myocardial infarction - drug therapy |
1 |
|
national institutes of health (u.s.) |
1 |
|
near-infrared spectroscopy (nirs) |
1 |
|
neovascularization, physiologic - physiology |
1 |
|
nervous system diseases - etiology - therapy |
1 |
|
neural plasticity |
1 |
|
neurogenesis |
1 |
|
neuroglia - metabolism |
1 |
|
neurologic examination |
1 |
|
neurological clinic |
1 |
|
neurological complications |
1 |
|
neurology - standards |
1 |
|
neuromuscular diseases - etiology - physiopathology - therapy |
1 |
|
neuronal cells |
1 |
|
neuronal death |
1 |
|
neuronal nitric oxide synthase |
1 |
|
neurons - drug effects - metabolism - pathology |
1 |
|
neurons - drug effects - pathology |
1 |
|
neurons - metabolism |
1 |
|
neuropeptide y |
1 |
|
neuropeptide y - administration & dosage - pharmacology |
1 |
|
neuropeptide y - adverse effects - analogs & derivatives - pharmacology |
1 |
|
neuropeptide y - analysis - metabolism |
1 |
|
neuropeptide y - biosynthesis |
1 |
|
neuropeptide y - metabolism |
1 |
|
neuropeptide y - metabolism - pharmacology - physiology |
1 |
|
neuropeptide y - pharmacology |
1 |
|
neuropeptide y receptor |
1 |
|
neuropeptides - analysis - metabolism |
1 |
|
neuropeptides - metabolism |
1 |
|
neuroprotection |
1 |
|
neuroprotective agents - administration & dosage |
1 |
|
neuroprotective agents - pharmacology |
1 |
|
neuroprotective agents - therapeutic use |
1 |
|
neurosurgical procedures |
1 |
|
neurotensin |
1 |
|
neurotensin - analysis - metabolism |
1 |
|
neurotensin - metabolism |
1 |
|
neurotoxins - pharmacology |
1 |
|
nitric oxide - metabolism |
1 |
|
nitric oxide synthase - metabolism |
1 |
|
nitric oxide synthase type i |
1 |
|
nitric oxide synthase type iii |
1 |
|
nocardia asteroides - isolation & purification |
1 |
|
nocardia infections - complications - microbiology |
1 |
|
noise stress |
1 |
|
north america - epidemiology |
1 |
|
npy |
1 |
|
npy receptor analogs |
1 |
|
ophthalmic artery - physiopathology - ultrasonography |
1 |
|
optokinetic after-nystagmus |
1 |
|
optokinetic nystagmus |
1 |
|
outcome assessment (health care) - methods |
1 |
|
oxygen - metabolism |
1 |
|
oxygen-glucose deprivation |
1 |
|
peptide fragments - pharmacology |
1 |
|
perfusion |
1 |
|
perfusion magnetic resonance imaging |
1 |
|
peripheral visual field |
1 |
|
peroxidase - metabolism |
1 |
|
personal satisfaction |
1 |
|
physician's practice patterns |
1 |
|
pilot projects |
1 |
|
pineal |
1 |
|
pituitary neoplasms |
1 |
|
placebos |
1 |
|
platelet aggregation inhibitors |
1 |
|
platelet aggregation inhibitors - adverse effects |
1 |
|
platelet count |
1 |
|
praziquantel - adverse effects - therapeutic use |
1 |
|
predictive value of tests |
1 |
|
prefrontal cortex - pathology |
1 |
|
prophylaxis |
1 |
|
proportional hazards models |
1 |
|
prostaglandin-endoperoxide synthases - deficiency - genetics - physiology |
1 |
|
prostaglandin-endoperoxide synthases - metabolism |
1 |
|
protein isoforms |
1 |
|
pulmonary edema |
1 |
|
purpura, thrombotic thrombocytopenic - chemically induced |
1 |
|
putonghua |
1 |
|
quality of life |
1 |
|
randomized controlled trials as topic - statistics & numerical data |
1 |
|
rats, wistar |
1 |
|
rats, wistar - physiology |
1 |
|
reactive oxygen species |
1 |
|
receptors, cell surface - biosynthesis |
1 |
|
receptors, cytoplasmic and nuclear - biosynthesis |
1 |
|
receptors, melatonin |
1 |
|
receptors, neuropeptide y - agonists - antagonists & inhibitors - metabolism |
1 |
|
receptors, neuropeptide y - antagonists & inhibitors - metabolism |
1 |
|
receptors, neuropeptide y - metabolism - physiology |
1 |
|
recombinant proteins |
1 |
|
recurrent headache |
1 |
|
reflex arc |
1 |
|
reliability |
1 |
|
renovascular hypertension |
1 |
|
reperfusion |
1 |
|
reperfusion injury |
1 |
|
reperfusion injury - complications |
1 |
|
reperfusion injury - drug therapy - metabolism - pathology |
1 |
|
reperfusion injury - drug therapy - physiopathology |
1 |
|
reproducibility of results |
1 |
|
respiration |
1 |
|
reverse transcriptase polymerase chain reaction |
1 |
|
risk assessment |
1 |
|
seizure |
1 |
|
sensorimotor behavior |
1 |
|
sex |
1 |
|
sex distribution |
1 |
|
sexual behavior - physiology - psychology |
1 |
|
sexual dysfunction, physiological - etiology |
1 |
|
sexual dysfunctions, psychological - ethnology - psychology |
1 |
|
sexual dysfunctions, psychological - etiology |
1 |
|
sexuality |
1 |
|
shsy5y neuroblastoma cells |
1 |
|
silent stroke |
1 |
|
stress, physiological - physiopathology |
1 |
|
stroke - complications - physiopathology - psychology |
1 |
|
stroke - diagnosis - mortality |
1 |
|
stroke - diagnosis - physiopathology - prevention & control |
1 |
|
stroke - enzymology - genetics |
1 |
|
stroke - epidemiology - psychology |
1 |
|
stroke - etiology - prevention & control |
1 |
|
stroke - metabolism |
1 |
|
stroke - metabolism - pathology |
1 |
|
stroke - physiopathology - psychology |
1 |
|
stroke - therapy |
1 |
|
stroke - ultrasonography |
1 |
|
stroke model |
1 |
|
stroke outcome measures |
1 |
|
stroke scales |
1 |
|
stroke, experimental |
1 |
|
subarachnoid haemorrhage |
1 |
|
subarachnoid hemorrhage - therapy |
1 |
|
surgical treatment |
1 |
|
survival analysis |
1 |
|
systole |
1 |
|
temperature |
1 |
|
tension-type headache |
1 |
|
tension-type headache - epidemiology |
1 |
|
tetanus - complications - diagnosis - therapy |
1 |
|
tetrazolium salts - pharmacology |
1 |
|
thalamus - anatomy and histology - pathology - physiology |
1 |
|
thiazoles - pharmacology |
1 |
|
thrombocytopenia - chemically induced |
1 |
|
thrombolysis |
1 |
|
thrombolytic therapy |
1 |
|
thrombolytic therapy - adverse effects |
1 |
|
thrombosis - metabolism |
1 |
|
ticlopidine - adverse effects - analogs & derivatives - therapeutic use |
1 |
|
time window |
1 |
|
tomography, emission-computed |
1 |
|
transient ischemic attack |
1 |
|
trigeminal nerve |
1 |
|
triphenyltetrazolium chloride |
1 |
|
tyrosine 3-monooxygenase - metabolism |
1 |
|
tyrosine hydroxylase |
1 |
|
ultrasonography, doppler, duplex |
1 |
|
ultrasonography, doppler, transcranial |
1 |
|
ultrasonography, doppler, transcranial - methods |
1 |
|
united states |
1 |
|
velocity storage mechanism |
1 |
|
vertebral artery |
1 |
|
vertebral artery - abnormalities |
1 |
|
vertebrobasilar insufficiency - drug therapy - radiography - ultrasonography |
1 |
|
vestibular |
1 |
|
videotape recording - standards |
1 |
|
visually induced motion sickness |
1 |
|
whole-body motion |
1 |
|
yoga |
1 |
|
啟示 |
1 |
|
對比 |
1 |
|
臨床醫生 |
1 |
|
香港醫療 |
1 |
